ArticleBMC infectious diseases2024

The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody.

Shuhei Maruyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.